HK1248140A1 - 用於治療癌症或免疫性疾病的細胞外基質組合物 - Google Patents
用於治療癌症或免疫性疾病的細胞外基質組合物Info
- Publication number
- HK1248140A1 HK1248140A1 HK18107811.2A HK18107811A HK1248140A1 HK 1248140 A1 HK1248140 A1 HK 1248140A1 HK 18107811 A HK18107811 A HK 18107811A HK 1248140 A1 HK1248140 A1 HK 1248140A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- cancer
- treatment
- extracellular matrix
- immunological diseases
- matrix compositions
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/33—Fibroblasts
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/48—Reproductive organs
- A61K35/54—Ovaries; Ova; Ovules; Embryos; Foetal cells; Germ cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/014—Hydrolysed proteins; Derivatives thereof from animals from connective tissue peptides, e.g. gelatin, collagen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues
- C12N5/0602—Vertebrate cells
- C12N5/0652—Cells of skeletal and connective tissues; Mesenchyme
- C12N5/0656—Adult fibroblasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/32—Amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/30—Organic components
- C12N2500/34—Sugars
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2500/00—Specific components of cell culture medium
- C12N2500/70—Undefined extracts
- C12N2500/80—Undefined extracts from animals
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2533/00—Supports or coatings for cell culture, characterised by material
- C12N2533/90—Substrates of biological origin, e.g. extracellular matrix, decellularised tissue
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Biomedical Technology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Cell Biology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Developmental Biology & Embryology (AREA)
- Virology (AREA)
- Genetics & Genomics (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Rheumatology (AREA)
- Biochemistry (AREA)
- Microbiology (AREA)
- Reproductive Health (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Gynecology & Obstetrics (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201562155360P | 2015-04-30 | 2015-04-30 | |
PCT/US2016/030204 WO2016176620A1 (en) | 2015-04-30 | 2016-04-29 | Extracellular matirix compositions for the treatment of cancer or immunological diseases |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1248140A1 true HK1248140A1 (zh) | 2018-10-12 |
Family
ID=57199820
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK18107811.2A HK1248140A1 (zh) | 2015-04-30 | 2018-06-15 | 用於治療癌症或免疫性疾病的細胞外基質組合物 |
Country Status (9)
Country | Link |
---|---|
US (1) | US11191780B2 (zh) |
EP (1) | EP3288565A4 (zh) |
JP (2) | JP2018518463A (zh) |
KR (1) | KR20170141788A (zh) |
CN (1) | CN107735097A (zh) |
AU (1) | AU2016256455A1 (zh) |
CA (1) | CA2983832A1 (zh) |
HK (1) | HK1248140A1 (zh) |
WO (1) | WO2016176620A1 (zh) |
Families Citing this family (8)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US10533191B2 (en) | 2014-01-15 | 2020-01-14 | Serucell Corporation | Therapeutic serum obtained from co-cultured cells |
WO2017087870A1 (en) * | 2015-11-18 | 2017-05-26 | Bristol-Myers Squibb Company | Treatment of lung cancer using a combination of an anti-pd-1 antibody and an anti-ctla-4 antibody |
CN107349417A (zh) * | 2017-04-01 | 2017-11-17 | 南阳市中心医院 | 一种治疗食管鳞癌的ecm复合物以及其在制备治疗食管鳞癌的药物中的用途 |
WO2019118686A1 (en) * | 2017-12-13 | 2019-06-20 | North Carolina State University | Compositions comprising chemotherapeutic agents and checkpoint inhibitors and methods of use |
AU2019315502A1 (en) * | 2018-08-02 | 2021-03-18 | Histogen, Inc. | Conditioned medium and extracellular matrix compositions and uses thereof |
KR20200040536A (ko) * | 2018-10-10 | 2020-04-20 | 사회복지법인 삼성생명공익재단 | 저산소 조건에서 섬유아세포를 배양하여 제조한 조정배지를 포함하는 암세포 사멸 유도용 조성물 및 이의 제조 방법 |
US20220143179A1 (en) * | 2019-03-04 | 2022-05-12 | North Carolina State University | Drug delivery for combination of epigenetic modulation and immune checkpoint blockade |
EP3909600A1 (en) * | 2020-05-12 | 2021-11-17 | International Centre For Genetic Engineering And Biotechnology - ICGEB | Emid2 protein as anti-cancer treatment |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2403508A1 (en) * | 2000-04-18 | 2001-10-25 | Human Genome Sciences, Inc. | Extracellular matrix polynucleotides, polypeptides, and antibodies |
WO2006130620A2 (en) | 2005-05-31 | 2006-12-07 | President And Fellows Of Harvard College | Modulation of t cell recruitment |
US8778362B2 (en) * | 2005-10-27 | 2014-07-15 | University Of Notre Dame | Anti-tumor/cancer heterologous acellular collagenous preparations and uses thereof |
EP2365815B1 (en) * | 2008-11-14 | 2019-09-18 | Histogen, Inc. | Extracellular matrix compositions for the treatment of cancer |
US20140205609A1 (en) | 2013-01-24 | 2014-07-24 | Fred T. Valentine | Methods for inducing systemic immune responses to cancer |
US10111898B2 (en) * | 2014-08-27 | 2018-10-30 | Peptimed, Inc. | Anti-tumor compositions and methods |
-
2016
- 2016-04-29 CN CN201680032036.5A patent/CN107735097A/zh active Pending
- 2016-04-29 WO PCT/US2016/030204 patent/WO2016176620A1/en active Application Filing
- 2016-04-29 KR KR1020177034641A patent/KR20170141788A/ko not_active Application Discontinuation
- 2016-04-29 JP JP2017556808A patent/JP2018518463A/ja active Pending
- 2016-04-29 EP EP16787257.1A patent/EP3288565A4/en not_active Withdrawn
- 2016-04-29 US US15/569,284 patent/US11191780B2/en active Active
- 2016-04-29 CA CA2983832A patent/CA2983832A1/en not_active Abandoned
- 2016-04-29 AU AU2016256455A patent/AU2016256455A1/en not_active Abandoned
-
2018
- 2018-06-15 HK HK18107811.2A patent/HK1248140A1/zh unknown
-
2021
- 2021-07-09 JP JP2021114121A patent/JP2021183607A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
EP3288565A1 (en) | 2018-03-07 |
JP2021183607A (ja) | 2021-12-02 |
AU2016256455A1 (en) | 2017-12-07 |
US20180117092A1 (en) | 2018-05-03 |
CA2983832A1 (en) | 2016-11-03 |
WO2016176620A1 (en) | 2016-11-03 |
KR20170141788A (ko) | 2017-12-26 |
EP3288565A4 (en) | 2019-02-13 |
US11191780B2 (en) | 2021-12-07 |
CN107735097A (zh) | 2018-02-23 |
WO2016176620A8 (en) | 2017-11-16 |
JP2018518463A (ja) | 2018-07-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP3448874A4 (en) | COMPOSITIONS FOR TREATING A DISEASE | |
EP3448875A4 (en) | COMPOSITIONS FOR TREATING A DISEASE | |
EP3448987A4 (en) | COMPOSITIONS FOR THE TREATMENT OF DISEASES | |
HK1247202A1 (zh) | 用於治療癌症的化合物 | |
SG11201705093UA (en) | Composition for treating il-6-related diseases | |
SG11201801024XA (en) | Therapeutic or preventive compositions for il-8-related diseases | |
HK1248140A1 (zh) | 用於治療癌症或免疫性疾病的細胞外基質組合物 | |
HK1256795A1 (zh) | 可用於治療自身免疫疾病的二吡唑基衍生物 | |
IL258997B (en) | Honey-cannabinoid therapeutic composition | |
IL259996A (en) | Combinations for cancer treatment | |
EP3229793A4 (en) | Compositions and methods relating to the treatment of cancer, autoimmune disease, and neurodegenerative disease | |
IL261278A (en) | Pharmaceutical compositions for the treatment of cancer | |
PL3302573T3 (pl) | Kompozycja do leczenia uszkodzeń mózgu | |
IL275525A (en) | A pharmaceutical preparation for the treatment of cancer | |
EP3096775A4 (en) | Socs mimetics for the treatment of diseases | |
ZA201707024B (en) | Cancer treatment composition | |
EP3341002A4 (en) | HERBAL COMPOSITION FOR THE TREATMENT OF AGE-BURNING MOLECULAR DISEASES | |
IL259381B (en) | Miravegron for the treatment of retinal diseases | |
EP3362085C0 (en) | COMPOSITIONS FOR THE TREATMENT OF DISEASES WITH MUCIN | |
EP3371210A4 (en) | COMBINATION THERAPY FOR MALIGNINE DISEASES | |
IL255167A0 (en) | Compounds for the treatment of cancer | |
EP3242681B8 (en) | Novel compounds for the treatment of cancer | |
PL3164110T3 (pl) | Kompozycje farmaceutyczne do leczenia łuszczycy | |
DK3579865T3 (en) | Therapeutic compositions | |
GB201719584D0 (en) | Pharmaceutical compositions for the treatment of cancer |